Interestingly, TGF-β1 mRNA levels were downregulated in PC3-shESS2 cells (Fig. 5h), and ESS2 and TGF-β1 expression levels were significantly correlated in patients with prostate cancer (Fig. 5i). The gene discussed is ESS2; the disease is prostate carcinoma.